Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS Medical Dialogues Bureau25 Feb 2020 1:03 PM IST"With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...